Ornithine decarboxylase in resting human mononuclear leucocytes: evidence for an endogenous inhibitor.
1. Ornithine decarboxylase (ODC) was measured in human mononuclear leucocytes (HML) by retention of putrescine on cation exchange paper. 2. The method was validated with unstimulated HML, phytohemagglutinin-stimulated HML, and a commercial preparation of ODC. The average enzyme activity of unstimulated HML (50 samples) was 22.6 +/- 7.3 pmol/hr 10(7) cells, with 29 values less than 5 pmol/hr 107 cells. 3. The results show that an endogenous inhibitor or inactivator of ODC exists in unstimulated HML: enzyme activity in extracts of mitogen-stimulated cells were inhibited by extracts of unstimulated cells (37-55%) inhibition under the conditions used.
Johnson
D B
DB
Preventive Medicine Institute Strang Clinic, New York, NY 10016.
Pero
R W
RW
Morgenstern
R
R
Joseph
P E
PE
Miller
D G
DG
D002411:Cation Exchange Resins; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000201:enzymology*; D009955:Ornithine Decarboxylase / Q000097:blood*; D065108:Ornithine Decarboxylase Inhibitors; D011700:Putrescine / Q000096:biosynthesis; D013936:Thymidine
D002411:Cation Exchange Resins; D065108:Ornithine Decarboxylase Inhibitors; D009955:Ornithine Decarboxylase; D011700:Putrescine; D013936:Thymidine